Recipient CTLA-4*CT60-AA genotype is a prognostic factor for acute graft-versus-host disease in hematopoietic stem cell transplantation for thalassemia

Sandro Orrù, Nicola Orrù, Emmanouil Manolakos, Roberto Littera, Giovanni Caocci, Giovanna Giorgiani, Alice Bertaina, Daria Pagliara, Claudio Giardini, Sonia Nesci, Franco Locatelli, Carlo Carcassi, Giorgio La Nasa

Research output: Contribution to journalArticle

Abstract

Polymorphisms of the cytotoxic T-lymphocyte antigen-4 gene (CTLA-4) have been associated with autoimmune diseases and it has recently been reported that donor genotypes correlate with the outcome of allogeneic hematopoietic stem cell transplantation in leukemia patients. With the aim of confirming this finding in thalassemia patients, we investigated the influence of genotype distribution of 3 CTLA-4 gene polymorphisms in 72 thalassemia patients and their unrelated donors. A significant association was observed for recipient CT60-AA genotype and onset of grade II-IV (63.2% vs 24.5%; p = 0.001) and grade III-IV (36.4% vs 7.6%; p = 0.005) acute graft-versus-host disease (aGVHD). The same association was observed for the 88-base-pair allele of the CTLA-4 (AT)n polymorphism, which was determined to be in complete linkage disequilibrium with the CT60 A allele. Multinomial Cox regression demonstrated that this association was independent of CT60 donor genotypes or other risk factors (p = 0.016; hazard ratio = 2.8). Our data confirm that the genetic variability in CTLA-4 is an important prognostic factor for aGVHD and suggest that some of the risk factors for this complication are generated by recipient cells that persist after the myeloablative conditioning regimen.

Original languageEnglish
Pages (from-to)282-286
Number of pages5
JournalHuman Immunology
Volume73
Issue number3
DOIs
Publication statusPublished - Mar 2012

Fingerprint

CTLA-4 Antigen
Thalassemia
Hematopoietic Stem Cell Transplantation
Graft vs Host Disease
Genotype
Genes
Alleles
Tissue Donors
Unrelated Donors
Linkage Disequilibrium
Base Pairing
Autoimmune Diseases
Leukemia

Keywords

  • Acute GVHD
  • Allogeneic HSCT
  • CTLA-4
  • Thalassemia

ASJC Scopus subject areas

  • Immunology
  • Immunology and Allergy

Cite this

Recipient CTLA-4*CT60-AA genotype is a prognostic factor for acute graft-versus-host disease in hematopoietic stem cell transplantation for thalassemia. / Orrù, Sandro; Orrù, Nicola; Manolakos, Emmanouil; Littera, Roberto; Caocci, Giovanni; Giorgiani, Giovanna; Bertaina, Alice; Pagliara, Daria; Giardini, Claudio; Nesci, Sonia; Locatelli, Franco; Carcassi, Carlo; La Nasa, Giorgio.

In: Human Immunology, Vol. 73, No. 3, 03.2012, p. 282-286.

Research output: Contribution to journalArticle

Orrù, Sandro ; Orrù, Nicola ; Manolakos, Emmanouil ; Littera, Roberto ; Caocci, Giovanni ; Giorgiani, Giovanna ; Bertaina, Alice ; Pagliara, Daria ; Giardini, Claudio ; Nesci, Sonia ; Locatelli, Franco ; Carcassi, Carlo ; La Nasa, Giorgio. / Recipient CTLA-4*CT60-AA genotype is a prognostic factor for acute graft-versus-host disease in hematopoietic stem cell transplantation for thalassemia. In: Human Immunology. 2012 ; Vol. 73, No. 3. pp. 282-286.
@article{ff2a57cbf044420485da879cfdffe2cd,
title = "Recipient CTLA-4*CT60-AA genotype is a prognostic factor for acute graft-versus-host disease in hematopoietic stem cell transplantation for thalassemia",
abstract = "Polymorphisms of the cytotoxic T-lymphocyte antigen-4 gene (CTLA-4) have been associated with autoimmune diseases and it has recently been reported that donor genotypes correlate with the outcome of allogeneic hematopoietic stem cell transplantation in leukemia patients. With the aim of confirming this finding in thalassemia patients, we investigated the influence of genotype distribution of 3 CTLA-4 gene polymorphisms in 72 thalassemia patients and their unrelated donors. A significant association was observed for recipient CT60-AA genotype and onset of grade II-IV (63.2{\%} vs 24.5{\%}; p = 0.001) and grade III-IV (36.4{\%} vs 7.6{\%}; p = 0.005) acute graft-versus-host disease (aGVHD). The same association was observed for the 88-base-pair allele of the CTLA-4 (AT)n polymorphism, which was determined to be in complete linkage disequilibrium with the CT60 A allele. Multinomial Cox regression demonstrated that this association was independent of CT60 donor genotypes or other risk factors (p = 0.016; hazard ratio = 2.8). Our data confirm that the genetic variability in CTLA-4 is an important prognostic factor for aGVHD and suggest that some of the risk factors for this complication are generated by recipient cells that persist after the myeloablative conditioning regimen.",
keywords = "Acute GVHD, Allogeneic HSCT, CTLA-4, Thalassemia",
author = "Sandro Orr{\`u} and Nicola Orr{\`u} and Emmanouil Manolakos and Roberto Littera and Giovanni Caocci and Giovanna Giorgiani and Alice Bertaina and Daria Pagliara and Claudio Giardini and Sonia Nesci and Franco Locatelli and Carlo Carcassi and {La Nasa}, Giorgio",
year = "2012",
month = "3",
doi = "10.1016/j.humimm.2011.12.014",
language = "English",
volume = "73",
pages = "282--286",
journal = "Human Immunology",
issn = "0198-8859",
publisher = "Elsevier Inc.",
number = "3",

}

TY - JOUR

T1 - Recipient CTLA-4*CT60-AA genotype is a prognostic factor for acute graft-versus-host disease in hematopoietic stem cell transplantation for thalassemia

AU - Orrù, Sandro

AU - Orrù, Nicola

AU - Manolakos, Emmanouil

AU - Littera, Roberto

AU - Caocci, Giovanni

AU - Giorgiani, Giovanna

AU - Bertaina, Alice

AU - Pagliara, Daria

AU - Giardini, Claudio

AU - Nesci, Sonia

AU - Locatelli, Franco

AU - Carcassi, Carlo

AU - La Nasa, Giorgio

PY - 2012/3

Y1 - 2012/3

N2 - Polymorphisms of the cytotoxic T-lymphocyte antigen-4 gene (CTLA-4) have been associated with autoimmune diseases and it has recently been reported that donor genotypes correlate with the outcome of allogeneic hematopoietic stem cell transplantation in leukemia patients. With the aim of confirming this finding in thalassemia patients, we investigated the influence of genotype distribution of 3 CTLA-4 gene polymorphisms in 72 thalassemia patients and their unrelated donors. A significant association was observed for recipient CT60-AA genotype and onset of grade II-IV (63.2% vs 24.5%; p = 0.001) and grade III-IV (36.4% vs 7.6%; p = 0.005) acute graft-versus-host disease (aGVHD). The same association was observed for the 88-base-pair allele of the CTLA-4 (AT)n polymorphism, which was determined to be in complete linkage disequilibrium with the CT60 A allele. Multinomial Cox regression demonstrated that this association was independent of CT60 donor genotypes or other risk factors (p = 0.016; hazard ratio = 2.8). Our data confirm that the genetic variability in CTLA-4 is an important prognostic factor for aGVHD and suggest that some of the risk factors for this complication are generated by recipient cells that persist after the myeloablative conditioning regimen.

AB - Polymorphisms of the cytotoxic T-lymphocyte antigen-4 gene (CTLA-4) have been associated with autoimmune diseases and it has recently been reported that donor genotypes correlate with the outcome of allogeneic hematopoietic stem cell transplantation in leukemia patients. With the aim of confirming this finding in thalassemia patients, we investigated the influence of genotype distribution of 3 CTLA-4 gene polymorphisms in 72 thalassemia patients and their unrelated donors. A significant association was observed for recipient CT60-AA genotype and onset of grade II-IV (63.2% vs 24.5%; p = 0.001) and grade III-IV (36.4% vs 7.6%; p = 0.005) acute graft-versus-host disease (aGVHD). The same association was observed for the 88-base-pair allele of the CTLA-4 (AT)n polymorphism, which was determined to be in complete linkage disequilibrium with the CT60 A allele. Multinomial Cox regression demonstrated that this association was independent of CT60 donor genotypes or other risk factors (p = 0.016; hazard ratio = 2.8). Our data confirm that the genetic variability in CTLA-4 is an important prognostic factor for aGVHD and suggest that some of the risk factors for this complication are generated by recipient cells that persist after the myeloablative conditioning regimen.

KW - Acute GVHD

KW - Allogeneic HSCT

KW - CTLA-4

KW - Thalassemia

UR - http://www.scopus.com/inward/record.url?scp=84857116061&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84857116061&partnerID=8YFLogxK

U2 - 10.1016/j.humimm.2011.12.014

DO - 10.1016/j.humimm.2011.12.014

M3 - Article

C2 - 22245568

AN - SCOPUS:84857116061

VL - 73

SP - 282

EP - 286

JO - Human Immunology

JF - Human Immunology

SN - 0198-8859

IS - 3

ER -